© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003

References 5400-5499

5400. P.G. Gallagher, L. Kotula, Y. Wang, S.L. Marchesi, P.J. Curtis, D.W. Speicher, B.G. Forget, “Molecular basis and haplotyping of the alphaII domain polymorphisms of spectrin: application to the study of hereditary elliptocytosis and pyropoikilocytosis,” Am. J. Hum. Genet. 59(August 1996):351-359.

5401. J.C. Hansen, R. Skalak, S. Chien, A. Hoger, “Influence of network topology on the elasticity of the red blood cell membrane skeleton,” Biophys. J. 72(May 1997):2369-2381.

5402. L.D. Walensky, Z.T. Shi, S. Blackshaw, A.C. DeVries, G.E. Demas, P. Gascard, R.J. Nelson, J.G. Conboy, E.M. Rubin, S.H. Snyder, N. Mohandas, “Neurobehavioral deficits in mice lacking the erythrocyte membrane cytoskeletal protein 4.1,” Curr. Biol. 8(19 November 1998):1269-1272.

5403. A.F. Muro, M.L. Marro, S. Gajovic, F. Porro, L. Luzzatto, F.E. Baralle, “Mild spherocytic hereditary elliptocytosis and altered levels of alpha- and gamma-adducins in beta-adducin-deficient mice,” Blood 95(15 June 2000):3978-3985; http://www.bloodjournal.org/cgi/content/full/95/12/3978

5404. Z. Zhang, S.A. Weed, P.G. Gallagher, J.S. Morrow, “Dynamic molecular modeling of pathogenic mutations in the spectrin self-association domain,” Blood 98(15 September 2001):1645-1653.

5405. J. Delaunay, “Genetic disorders of the red cell membranes,” FEBS Lett 369(1 August 1995):34-37.

5406. Y. Yawata, A. Kanzaki, T. Inoue, K. Ata, H. Wada, N. Okamoto, I. Higo, A. Yawata, T. Sugihara, O. Yamada, “Red cell membrane disorders in the Japanese population: clinical, biochemical, electron microscopic, and genetic studies,” Int. J. Hematol. 60(July 1994):23-38. See also: Y. Yawata, “Characteristics of red cell membrane disorders in the Japanese population,” Rinsho Byori 45(April 1997):367-376. In Japanese.

5407. E.J. Chambers, G.B. Bloomberg, S.M. Ring, M.J. Tanner, “Structural studies on the effects of the deletion in the red cell anion exchanger (band 3, AE1) associated with South East Asian ovalocytosis,” J. Mol. Biol. 285(22 January 1999):1289-1307.

5408. S. Perrotta, E.M. del Giudice, A. Iolascon, M. De Vivo, D. Di Pinto, S. Cutillo, B. Nobili, “Reversible erythrocyte skeleton destabilization is modulated by beta-spectrin phosphorylation in childhood leukemia,” Leukemia 15(March 2001):440-444.

5409. D. Greenstein, R.C. Kester, “The hemorheologic effects of hand-transmitted vibration,” Angiology 48(September 1997):813-819.

5410. D. Greenstein, R.C. Kester, “The role of leukocytes in the pathogenesis of vibration-induced white finger,” Angiology 49(November 1998):915-922.

5411. R. Skalak, S. Chien, “Rheology of blood cells as soft tissues,” Biorheology 19(1982):453-461.

5412. R.M. Hochmuth, “Measuring the mechanical properties of individual human blood cells,” J. Biomech. Eng. 115(November 1993):515-519.

5413. K. Sharma, “Cellular deformability studies in leukemia,” Physiol. Chem. Phys. Med. NMR 25(1993):293-297.

5414. T.W. Secomb, “Mechanics of blood flow in the microcirculation,” Symp. Soc. Exp. Biol. 49(1995):305-321.

5415. U. Bagge, B. Amundson, C. Lauritzen, “White blood cell deformability and plugging of skeletal muscle capillaries in hemorrhagic shock,” Acta Physiol. Scand. 108(February 1980):159-163.

5416. P.L. La Celle, “Alterations by leukocytes of erythrocyte flow in microchannels,” Blood Cells 12(1986):179-189.

5417. I. Vermes, F. Strik, “Altered leukocyte rheology in patients with chronic cerebrovascular disease,” Stroke 19(May 1988):631-633.

5418. M.J. Eppihimer, H.H. Lipowsky, “Leukocyte sequestration in the microvasculature in normal and low flow states,” Am. J. Physiol. 267(September 1994):H1122-H1134; M.J. Eppihimer, H.H. Lipowsky, “The mean filtration pressure of leukocyte suspensions and its relation to the passage of leukocytes through nuclepore filters and capillary networks,” Microcirculation 1(December 1994):237-250.

5419. H.S. Jacob, I.M. Goldstein, I. Shapiro, P.R. Craddock, D.E. Hammerschmidt, G. Weissmann, “Sudden blindness in acute pancreatitis. Possible role of complement-induced retinal leukoembolization,” Arch. Intern. Med. 141(January 1981):134-136.

5420. I. Shapiro, H.S. Jacob, “Leukoembolization in ocular vascular occlusion,” Ann. Ophthalmol. 14(January 1982):60-62.

5421. N. Arora, F.H. Lambrou Jr., M.W. Stewart, L. Vidrine-Parks, S. Sandroni, “Sudden blindness associated with central nervous symptoms in a hemodialysis patient,” Nephron 59(1991):490-492.

5422. D.E. Hammerschmidt, P.D. Harris, J.H. Wayland, P.R. Craddock, H.S. Jacob, “Complement-induced granulocyte aggregation in vivo,” Am. J. Pathol. 102(February 1981):146-150.

5423. T. Yasaka, L.A. Boxer, R.L. Baehner, “Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (fMLP) and platelet-activating factor (PAF),” J. Immunol. 128(May 1982):1939-1944.

5424. M.A. Boogaerts, C. Roelant, W. Goossens, R.L. Verwilghen, “Complement activation and adult respiratory distress syndrome during intermittent flow apheresis procedures,” Transfusion 26(January-February 1986):82-87.

5425. P.C. Adhikari, “Sensitivity of cholera and El Tor vibrios to cold shock,” J. Gen. Microbiol. 87(March 1975):163-166.

5426. P. Ghosh, R.M. Stroud, “Ion channels formed by a highly charged peptide,” Biochemistry 30(9 April 1991):3551-3557.

5427. K. Anzai, M. Hamasuna, H. Kadono, S. Lee, H. Aoyagi, Y. Kirino, “Formation of ion channels in planar lipid bilayer membranes by synthetic basic peptides,” Biochim. Biophys. Acta 1064(7 May 1991):256-266.

5428. T. Iwata, S. Lee, O. Oishi, H. Aoyagi, M. Ohno, K. Anzai, Y. Kirino, G. Sugihara, “Design and synthesis of amphipathic 3(10)-helical peptides and their interactions with phospholipid bilayers and ion channel formation,” J. Biol. Chem. 269(18 February 1994):4928-4933.

5429. A.D. Pechulis, R.J. Thompson, J.P. Fojtik, H.M. Schwartz, C.A. Lisek, L.L. Frye, “The design, synthesis and transmembrane transport studies of a biomimetic sterol-based ion channel,” Bioorg. Med. Chem. 5(October 1997):1893-1901.

5430. S. Futaki, “Peptide ion channels: design and creation of function,” Biopolymers 47(1998):75-81.

5431. D.P. Wallace, J.M. Tomich, J.W. Eppler, T. Iwamoto, J.J. Grantham, L.P. Sullivan, “A synthetic channel-forming peptide induces Cl(-) secretion: modulation by Ca(2+)-dependent K(+) channels,” Biochim. Biophys. Acta 1464(15 March 2000):69-82.

5432. E. Biron, N. Voyer, J.C. Meillon, M.E. Cormier, M. Auger, “Conformational and orientation studies of artificial ion channels incorporated into lipid bilayers,” Biopolymers 55(2000):364-372.

5433. G.W. Gokel, R. Ferdani, J. Liu, R. Pajewski, H. Shabany, P. Uetrecht, “Hydraphile channels: models for transmembrane, cation-conducting transporters,” Chemistry 7(5 January 2001):33-39; G.W. Gokel, “Synthetic, cation-conducting channels,” Sci. Prog. 81(1998):153-172.

5434. D. Wang, L. Guo, J. Zhang, L.R. Jones, Z. Chen, C. Pritchard, R.W. Roeske, “Artificial ion channels formed by a synthetic cyclic peptide,” J. Pept. Res. 57(April 2001):301-306.

5435. T.M. Fyles, C.W. Hu, R. Knoy, “Transmembrane ion conductance by an acyclic bolaamphiphile,” Org. Lett. 3(3 May 2001):1335-1337.

5436. H. Ishida, Z. Qi, M. Sokabe, K. Donowaki, Y. Inoue, “Molecular design and synthesis of artificial ion channels based on cyclic peptides containing unnatural amino acids,” J. Org. Chem. 66(4 May 2001):2978-2989.

5437. M. Montal, M.S. Montal, J.M. Tomich, “Synporins – synthetic proteins that emulate the pore structure of biological ionic channels,” Proc. Natl. Acad. Sci. (USA) 87(September 1990):6929-6933; http://www.pnas.org/cgi/reprint/87/18/6929

5438. S. Lee, T. Kiyota, T. Kunitake, E. Matsumoto, S. Yamashita, K. Anzai, G. Sugihara, “De novo design, synthesis, and characterization of a pore-forming small globular protein and its insertion into lipid bilayers,” Biochemistry 36(1 April 1997):3782-3791.

5439. H. Bayley, “Designed membrane channels and pores,” Curr. Opin. Biotechnol. 10(February 1999):94-103.

5440. E. Bamberg, H.J. Apell, H. Alpes, E. Gross, J.L. Morell, J.F. Harbaugh, K. Janko, P. Lauger, “Ion channels formed by chemical analogs of gramicidin A,” Fed. Proc. 37(October 1978):2633-2638.

5441. P. Grigoriev, R. Schlegel, K. Dornberger, U. Grafe, “Formation of membrane channels by chrysospermins, new peptaibol antibiotics,” Biochim. Biophys. Acta 1237(6 July 1995):1-5.

5442. R.E. Koeppe 2nd, O.S. Anderson, “Engineering the gramicidin channel,” Annu. Rev. Biophys. Biomol. Struct. 25(1996):231-258.

5443. Y. Sokolov, T. Mirzabekov, D.W. Martin, R.I. Lehrer, B.L. Kagan, “Membrane channel formation by antimicrobial protegrins,” Biochim. Biophys. Acta 1420(20 August 1999):23-29.

5444. M.R. Ghadiri, J.R. Granja, L.K. Buehler, “Artificial transmembrane ion channels from self-assembling peptide nanotubes,” Nature 369(26 May 1994):301-304, 276-277 (comment).

5445. A.J. Maniotis, C.S. Chen, D.E. Ingber, “Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure,” Proc. Natl. Acad. Sci. (USA) 94(4 February 1997):849-854; http://www.pnas.org/cgi/content/full/94/3/849

5446. Wendy E. Thomas, Elena Trintchina, Manu Forero, Viola Vogel, Evgeni Sokurenko, “Bacterial adhesion to target cells enhanced by shear force,” Cell 109(28 June 2002):913-923.

5447. R.B. Layzer, “Hot feet: erythromelalgia and related disorders,” J. Child Neurol. 16(March 2001):199-202.

5448. T. Mine, M. Kimura, A. Sakka, S. Kawai, “Innervation of nociceptors in the menisci of the knee joint: an immunohistochemical study,” Arch. Orthop. Trauma Surg. 120(2000):201-204; J.C. Gray, “Neural and vascular anatomy of the menisci of the human knee,” J. Orthop. Sports Phys. Ther. 29(January 1999):23-30.

5449. W. Magerl, G. Geldner, H.O. Handwerker, “Pain and vascular reflexes in man elicited by prolonged noxious mechano-stimulation,” Pain 43(November 1990):219-225.

5450. M.O. Urban, G.F. Gebhart, “Supraspinal contributions to hyperalgesia,” Proc. Natl. Acad. Sci. (USA) 96(6 July 1999):7687-7692; http://www.pnas.org/cgi/content/full/96/14/7687

5451. W. Janig, “Neurobiology of visceral afferent neurons: neuroanatomy, functions, organ regulations and sensations,” Biol. Psychol. 42(5 January 1996):29-51; F. Cervero, “Visceral pain: mechanisms of peripheral and central sensitization,” Ann. Med. 27(April 1995):235-239; F. Cervero, W. Janig, “Visceral nociceptors: a new world order?” Trends Neurosci. 15(October 1992):374-378.

5452. R.K. Snowball, R.A. Dampney, B.M. Lumb, “Responses of neurones in the medullary raphe nuclei to inputs from visceral nociceptors and the ventrolateral periaqueductal grey in the rat,” Exp. Physiol. 82(May 1997):485-500.

5453. Y. Senuma, S. Franceschin, J.G. Hilborn, P. Tissieres, I. Bisson, P. Frey, “Bioresorbable microspheres by spinning disk atomization as injectable cell carrier: from preparation to in vitro evaluation,” Biomaterials 21(June 2000):1135-1144.

5454. M. Bogataj, A. Mrhar, L. Korosec, “Influence of physicochemical and biological parameters on drug release from microspheres adhered on vesical and intestinal mucosa,” Int. J. Pharm. 177(25 January 1999):211-220.

5455. Bernard B. Davis, “Chapter 17-6. Pyuria,” in J. Willis Hurst, Medicine for the Practicing Physician, Third Edition, Butterworth-Heinemann, Boston MA, 1992, pp. 1229-1231; P. Froom, I. Shochat, J. Benbassat, “Factors associated with leukocyturia in asymptomatic pilots,” Aviat. Space Environ. Med. 62(September 1991):890-892.

5456. I. Lerman-Garber, J.J. Calva-Mercado, C. Martinez-Sibaja, C.F. del Castillo, R.M. Sanchez-Javier, E. Lara, I. Villalobos, F.J. Gomez-Perez, “Leukocyturia in women with diabetes and its clinical implications,” Arch. Med. Res. 31(March-April 2000):210-215.

5457. P.F. Abreu, L.R. Ramos, R. Sesso, “Abnormalities of renal function in the elderly,” Geriatr. Nephrol. Urol. 9(1999):141-145.

5458. J. Lesko, J.P. Johnston, “Oliguria,” AACN Clin. Issues 8(August 1997):459-468.

5459. M.A. Ghafar, A. Shabsigh, P. Chichester, A.G. Anastasiadis, A. Borow, R.M. Levin, R. Buttyan, “Effects of chronic partial outlet obstruction on blood flow and oxygenation of the rat bladder,” J. Urol. 167(March 2002):1508-1512.

5460. Z. Kaid-Omar, A. Belouatek, A. Driouch, H. Taleb-Bendiab, B. Lacour, A. Addou, M. Daudon, “Effects of diuretic therapy on spontaneous expulsion of urinary calculi, urinary pH, and crystalluria in lithiasic patients,” Prog. Urol. 11(June 2001):450-457.

5461. J.A. Hill, D.J. Anderson, “Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions,” Am. J. Obstet. Gynecol. 166(February 1992):720-726.

5462. D. Buchvald, P. Demes, A. Gombosova, P. Mraz, M. Valent, J. Stefanovic, “Vaginal leukocyte characteristics in urogenital trichomoniasis,” APMIS 100(May 1992):393-400.

5463. T. Yamada, S. Matsubara, H. Minakami, A. Ohkuchi, M. Hiratsuka, I. Sato, “Relation between viability of vaginal polymorphonuclear leukocytes and presence of histologic chorioamnionitis,” Acta Obstet. Gynecol. Scand. 79(October 2000):818-823.

5464. M.B. Parr, L. Kepple, E.L. Parr, “Langerhans cells phagocytose vaginal epithelial cells undergoing apoptosis during the murine estrous cycle,” Biol. Reprod. 45(August 1991):252-260.

5465. I.R. Radford, “Initiation of ionizing radiation-induced apoptosis: DNA damage-mediated or does ceramide have a role?” Int. J. Radiat. Biol. 75(May 1999):521-528.

5466. G.M. Li, “The role of mismatch repair in DNA damage-induced apoptosis,” Oncol. Res. 11(1999):393-400.

5467. P.A. Johnson, P. Clements, K. Hudson, K.W. Caldecott, “The mitotic spindle and DNA damage-induced apoptosis,” Toxicol. Lett. 112-113(15 March 2000):59-67; P.A. Johnson, P. Clements, K. Hudson, K.W. Caldecott, “A mitotic spindle requirement for DNA damage-induced apoptosis in Chinese hamster ovary cells,” Cancer Res. 59(1 June 1999):2696-2700; http://cancerres.aacrjournals.org/cgi/content/full/59/11/2696

5468. A. Terman, U.T. Brunk, “Lipofuscin: mechanisms of formation and increase with age,” APMIS 106(February 1998):265-276.

5469. U.T. Brunk, C.B. Jones, R.S. Sohal, “A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis,” Mutat. Res. 275(September 1992):395-403.

5470. D. Harman, “Lipofuscin and ceroid formation: the cellular recycling system,” Adv. Exp. Med. Biol. 266(1989):3-15.

5471. A.D. Blackett, D.A. Hall, “Tissue vitamin E levels and lipofuscin accumulation with age in the mouse,” J. Gerontol. 36(September 1981):529-533.

5472. J.M. Weimer, E. Kriscenski-Perry, Y. Elshatory, D.A. Pearce, “The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease,” Neuromolecular Med. 1(2002):111-124; R.D. Jolly, S. Brown, A.M. Das, S.U. Walkley, “Mitochondrial dysfunction in the neuronal ceroid-lipofuscinoses (Batten disease),” Neurochem. Int. 40(May 2002):565-571; E. Kida, A.A. Golabek, K.E. Wisniewski, “Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses,” Adv. Genet. 45(2001):35-68; M.A. Junaid, R.K. Pullarkat, “Biochemistry of neuronal ceroid lipofuscinoses,” Adv. Genet. 45(2001):93-106.

5473. A. Terman, H. Dalen, U.T. Brunk, “Ceroid/lipofuscin-loaded human fibroblasts show decreased survival time and diminished autophagocytosis during amino acid starvation,” Exp. Gerontol. 34(December 1999):943-957.

5474. J.J. Reinboth, K. Gautschi, K. Munz, G.E. Eldred, C.E. Reme, “Lipofuscin in the retina: quantitative assay for an unprecedented autofluorescent compound (pyridinium bis-retinoid, A2-E) of ocular age pigment,” Exp. Eye Res. 65(November 1997):639-643.

5475. U. Wihlmark, A. Wrigstad, K. Roberg, U.T. Brunk, S.E. Nilsson, “Formation of lipofuscin in cultured retinal pigment epithelial cells exposed to pre-oxidized photoreceptor outer segments,” APMIS 104(April 1996):272-279; C.J. Kennedy, P.E. Rakoczy, I.J. Constable, “Lipofuscin of the retinal pigment epithelium: a review,” Eye 9(1995):763-771.

5476. S. Carpenter, G. Karpati, “Lysosomal storage in human skeletal muscle,” Hum. Pathol. 17(July 1986):683-703.

5477. R.D. Jolly, “The mannosidoses and ceroid-lipofuscinoses: experimental studies on two types of storage disease,” Pathology 29(February 1997):51-56.

5478. R.D. Jolly, S.U. Walkley, “Lysosomal storage diseases of animals: an essay in comparative pathology,” Vet. Pathol. 34(November 1997):527-548.

5479. A.J. Brown, E.L. Mander, I.C. Gelissen, L. Kritharides, R.T. Dean, W. Jessup, “Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes,” J. Lipid Res. 41(February 2000):226-237; W. Jessup, L. Kritharides, “Metabolism of oxidized LDL by macrophages,” Curr. Opin. Lipidol. 11(October 2000):473-481; P.G. Yancey, W.G. Jerome, “Lysosomal sequestration of free and esterified cholesterol from oxidized low density lipoprotein in macrophages of different species,” J. Lipid Res. 39(July 1998):1349-1361.

5480. K.L. Ho, “Crystalloid bodies in skeletal muscle of hypothyroid myopathy. Ultrastructural and histochemical studies,” Acta Neuropathol (Berl) 74(1987):22-32.

5481. R.K. Tangirala, W.G. Jerome, N.L. Jones, D.M. Small, W.J. Johnson, J.M. Glick, F.H. Mahlberg, G.H. Rothblat, “Formation of cholesterol monohydrate crystals in macrophage-derived foam cells,” J. Lipid Res. 35(January 1994):93-104.

5482. T. Sattler, A. Mayer, “Cell-free reconstitution of microautophagic vacuole invagination and vesicle formation,” J. Cell Biol. 151(30 October 2000):529-538; http://www.jcb.org/cgi/content/full/151/3/529

5483. W. Bursch, A. Ellinger, C. Gerner, U. Frohwein, R. Schulte-Hermann, “Programmed cell death (PCD). Apoptosis, autophagic PCD, or others?” Ann. N.Y. Acad. Sci. 926(2000):1-12; W. Bursch, K. Hochegger, L. Torok, B. Marian, A. Ellinger, R.S. Hermann, “Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments,” J. Cell Sci. 113(April 2000):1189-1198; http://jcs.biologists.org/cgi/reprint/113/7/1189.pdf

5484. M.A. DiBerardino, N.J. Hoffner, L.D. Etkin, “Activation of dormant genes in specialized cells,” Science 224(1 June 1984):946-952.

5485. M. Ueda, A.E. Becker, T. Naruko, A. Kojima, “Smooth muscle cell de-differentiation is a fundamental change preceding wound healing after percutaneous transluminal coronary angioplasty in humans,” Coron. Artery Dis. 6(January 1995):71-81; K. Walsh, H. Perlman, “Molecular strategies to inhibit restenosis: modulation of the vascular myocyte phenotype,” Semin. Interv. Cardiol. 1(September 1996):173-179; A.M. Vignola, J. Kips, J. Bousquet, “Tissue remodeling as a feature of persistent asthma,” J. Allergy Clin. Immunol. 105(June 2000):1041-1053.

5486. J.F. Gauwerky, W.G. Forssmann, M. Kurz, R.P. Klose, G. Bastert, “Hydrosalpinx formation and its regeneration after microsurgical reconstruction – a functional and morphological study on rabbits,” Hum. Reprod. 9(November 1994):2090-2102; C. Michiels, N. Bouaziz, J. Remacle, “Role of the endothelium and blood stasis in the appearance of varicose veins,” Int. Angiol. 21(March 2002):1-8.

5487. Z. Zhang, X.M. Yuan, L.H. Li, F.P. Xie, “Transdifferentiation in neoplastic development and its pathological implication,” Histol. Histopathol. 16(October 2001):1249-1262; P. Mukunyadzi, R.D. Sanderson, C.Y. Fan, B.R. Smoller, “The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma,” Mod. Pathol. 15(January 2002):45-49.

5488. D.M. Livermore, “Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods,” Eur. J. Clin. Microbiol. 6(August 1987):439-445; S. Silver, G. Ji, “Newer systems for bacterial resistances to toxic heavy metals,” Environ. Health Perspect. 102(September 1994):107-113 (Suppl 3); V. Shingler, “Signal sensing by sigma 54-dependent regulators: derepression as a control mechanism,” Mol. Microbiol. 19(February 1996):409-416; Y. Murooka, H. Azakami, M. Yamashita, “The monoamine regulon including syntheses of arylsulfatase and monoamine oxidase in bacteria,” Biosci. Biotechnol. Biochem. 60(June 1996):935-941.

5489. Robert K. Stolting, Pharmacology and Physiology of Anesthetic Practice, Third Edition, Lippincott-Raven, Philadelphia, 1999.

5490. A Dictionary of Biology, Oxford University Press (Market House Books Ltd.), 2000.

5491. Abul K. Abbas, Andrew H. Lichtman, Jordan S. Pober, Cellular and Molecular Immunology, W.B. Saunders Company, Philadelphia, 1991.

5492. J. Feigon, T. Dieckmann, F.W. Smith, “Aptamer structures from A to zeta,” Chem. Biol. 3(August 1996):611-617; D.J. Patel, A.K. Suri, F. Jiang, L. Jiang, P. Fan, R.A. Kumar, S. Nonin, “Structure, recognition and adaptive binding in RNA aptamer complexes,” J. Mol. Biol. 272(10 October 1997):645-664; D.J. Patel, A.K. Suri, “Structure, recognition and discrimination in RNA aptamer complexes with cofactors, amino acids, drugs and aminoglycoside antibiotics,” J. Biotechnol. 74(March 2000):39-60; The Aptamer Database, http://aptamer.icmb.utexas.edu/index.html

5493. J. Bailey, M.J. Shapiro, “Abdominal compartment syndrome,” Crit. Care 4(2000):23-29; M.D. Perry, A. Manoli 2nd, “Foot compartment syndrome,” Orthop. Clin. North Am. 32(January 2001):103-111; J. Morken, M.A. West, “Abdominal compartment syndrome in the intensive care unit,” Curr. Opin. Crit. Care 7(August 2001):268-274.

5494. D.C. Smith, D.A. Mitchell, G.W. Peterson, A.D. Will, S.S. Mera, L.L. Smith, “Medial brachial fascial compartment syndrome: anatomic basis of neuropathy after transaxillary arteriography,” Radiology 173(October 1989):149-154; J.A. Ortiz Jr., R.A. Berger, “Compartment syndrome of the hand and wrist,” Hand Clin. 14(August 1998):405-418.

5495. M. Buerke, H.J. Rupprecht, “Antithrombotic therapy in acute coronary syndromes,” EXS 89(2000):193-209.

5496. H.L. Messmore Jr., “Heparin-induced thrombocytopenia: historical review,” Clin. Appl. Thromb. Hemost. 5(October 1999):S2-S6.

5497. T.M. Freeman, “Anaphylaxis: diagnosis and treatment,” Prim. Care 25(December 1998):809-817; C. Rusznak, R.S. Peebles Jr., “Anaphylaxis and anaphylactoid reactions. A guide to prevention, recognition, and emergent treatment,” Postgrad. Med. 111(May 2002):101-104, 107-108, 111-114.

5498. N. Klocker, W. Hanschke, S. Toussaint, T. Verse, “Scopolamine nasal spray in motion sickness: a randomised, controlled, and crossover study for the comparison of two scopolamine nasal sprays with oral dimenhydrinate and placebo,” Eur. J. Pharm. Sci. 13(May 2001):227-232.

5499. B.C. Wessels, M.T. Wells, S.L. Gaffin, J.G. Brock-Utne, P. Gathiram, L.B. Hinshaw, “Plasma endotoxin concentration in healthy primates and during E. coli-induced shock,” Crit. Care Med. 16(June 1988):601-605.

Last updated on 16 April 2004